PrimaryCareNOW: A Pri-Med Virtual Conference | Pri-Med

Thank you to all who joined us live for PrimaryCareNOW on Wednesday, August 24. If you were not able to join us live, some sessions have been recorded and are available below. 

Upcoming Virtual Conferences 
Pri-Med has more virtual education planned. View the schedule here.

Plan Your CME/CE Experiences

 

Agenda

  CME/CE Accredited Session

Non-CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in ET

8–9am ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on Gout and LGBTQ+ Mental Health

Peng Thim Fan, MD, FACP | Petros Levounis, MD, MA

 

What do primary care providers need to know about gout and LGBTQ+ mental health? Join expert faculty as they review important questions they get asked about these topics!

 

Peng Thim Fan, MD, FACP

Clinical Professor of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA

Petros Levounis, MD, MA

Professor and Chair, Department of Psychiatry, and, Associate Dean for Professional Development, Rutgers New Jersey Medical School

9:10–10:10am ET    CME/CE Accredited Session

Endocrinology

Weight Matters: Refocusing Diabetes Care in People with Obesity 

Jennifer B. Green, MD | Craig Primack, MD, FACP, FAAP, FOMA

 

PCPs stand on the frontlines of obesity management but often do not optimally provide the comprehensive and long-term care these patients require. Bias toward people with obesity can cloud clinical judgement, and comorbidities can take priority over addressing obesity. This expert-led session focuses on obesity as a serious, chronic illness and acknowledges intrinsic and extrinsic biases that negatively affect clinical judgment and relationships with patients. Clinicians will walk away with evidence-based strategies for obesity treatment that includes lifestyle interventions and long-term use of anti-obesity medications as indicated by recent guidelines. Finally, clinicians will hear about emerging treatment options that will likely expand their armamentarium.

Jennifer B. Green, MD

Professor of Medicine, Division of Endocrinology, Duke University School of Medicine, Duke Clinical Research Institute, Durham, NC

Craig Primack, MD, FACP, FAAP, FOMA

Co-Founder and Physician, Scottsdale Weight Loss Center, Immediate Past President, Obesity Medicine Association, Scottsdale, AZ

Supported by This activity is supported by an educational grant from Lilly

10:20–11:05am ET    Non-CME Industry Theater

Dermatology

Piecing it Together: Completing the Patient Picture to Identify Hidradenitis Suppurativa (HS) and Support Patient Care

Jennifer Hsiao, MD

 

  • Understand the chronic, progressive, and immune-mediated nature of HS by exploring a potential patient journey
  • Identify clinical signs and symptoms of HS for both adolescents and adults and the impact of timely diagnosis
  • Partner with a dermatologist for appropriate treatment when HS is suspected

Jennifer Hsiao, MD

Sponsored by AbbVie

10:20–11:05am ET    Non-CME Industry Theater

Pulmonology

A PRIMARY Focus on Shifting Treatment Paradigms in Asthma CARE

Susan Kuchera Fidler, MD

 

This session will use a patient case presentation to discuss: the burden and impact of uncontrolled asthma, tools for assessing asthma control, and key considerations in customizing asthma management, using a guidelines-based approach, to help identify appropriate treatment options for patients with uncontrolled asthma.

Susan Kuchera Fidler, MD

Sponsored by GSK

11:15am–12:15pm ET    CME/CE Accredited Session

Hot Topics

USPSTF Updates 2021-2022: What PCPs Need to Know

Charles Vega, MD, FAAFP

 

Stay up to date with the latest USPSTF recommendations for screening and preventive interventions in primary care. Walk away from this session with a firm grasp of the evidence of benefits vs harms for each of these recommendations so that you and your patients are positioned to make the best decisions for their care.

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine Director, UC Irvine Program in Medical Education for the Latino Community, Irvine, CA

12:25–1:25pm ET    CME/CE Accredited Session

Infectious Disease

 

As the first line of defense in recognizing and treating Clostridioides difficile infection, primary care providers need the most up-to-date clinical information to better understand how to diagnose and treat this common infection. In this session, experts will review the changing epidemiology of C difficile, current understanding of the pathophysiology of infection, and various diagnostic strategies. Current guideline recommendations for treating initial and recurrent C difficile will be discussed along with the latest data regarding current and emerging treatment options.

Paul Feuerstadt, MD, FACG, AGAF

Assistant Clinical Professor of Medicine, Yale University School of Medicine, Attending Gastroenterologist, PACT-Gastroenterology Center

Supported by Merck & Co., Inc

1:35–2:20pm ET    Non-CME Industry Theater

Rheumatology

Path To Diagnosis, Mapping Symptoms of Inflammatory Back Pain

Christopher Parker, DO

 

  • Understand the causes and prevalence of chronic low back pain
  • Differentiate inflammatory back pain (IBP) from mechanical back pain
  • Learn the significance of IBP as a potential early symptom of ankylosing spondylitis (AS)
  • Learn the importance of referring patients with IBP to a rheumatologist in a timely manner

Christopher Parker, DO

Sponsored by AbbVie

1:35–2:20pm ET    Non-CME Industry Theater

Cardiology

Clinical Insights in PAD: Reducing the Risk of Major Thrombotic Vascular Events

Sonya Noor, MD, FACS

 

This lecture will discuss treatment and reduction in the risk of major thrombotic vascular events (myocardial infarction, ischemic stroke, acute limb ischemia, and major amputation of a vascular etiology) in patients with peripheral artery disease (PAD), including patients after lower extremity revascularization due to symptomatic PAD

Sonya Noor, MD, FACS

Sponsored by Janssen Pharmaceuticals, Inc.

2:30–3:30pm ET    CME/CE Accredited Session

Hot Topics

Curbside Consults: Top Questions from PCPs on NASH and Mild Cognitive Impairment

Lee A. Lindquist, MD, MPH, MBA | Sammy Saab, MD, MPH, AGAF

 

What do primary care providers need to know about NASH and Mild Cognitive Impairment? Join expert faculty as they review important questions they get asked about these topics!

Lee A. Lindquist, MD, MPH, MBA

Chief of Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL

Sammy Saab, MD, MPH, AGAF

Medical Director, Pfleger Liver Institute at UCLA, Medical Director, UCLA Adult Liver Transplant Program, Chief, UCLA Transplant Hepatology, Head, Outcomes Research in Hepatology at UCLA, Professor of Medicine and Surgery, UCLA, Adjunct Professor of Nursing, UCLA, Los Angeles, CA , ,

3:40–4:40pm ET    CME/CE Accredited Session

Infectious Disease

COVID-19 Panel Discussion

Kalpana Gupta, MD, MPH | Laila Woc-Colburn, MD

 

This pandemic requires communication among specialists and primary care clinicians. In this COVID-19 panel, expert faculty will team up to discuss the most pressing and frequently asked questions about the disease and its complications.

 

Kalpana Gupta, MD, MPH

Kalpana Gupta, MD, MPH

Professor of Medicine, Boston University School of Medicine, Boston, MA

Laila Woc-Colburn, MD

Associate Professor, Division of Infectious Diseases Emory University School of Medicine, Atlanta, GA

4:50–5:35pm ET    Non-CME Industry Theater

Cardiovascular Medicine

Addressing Elevated Risk For Thrombotic CV Events in Patients Across the CAD Spectrum

Ted Okerson, MD, FACP, FACE

 

  • Understand the risk factors that contribute to the elevated risk for thrombotic cardiovascular events pre- and post-myocardial infarction in patients across the coronary artery disease spectrum
  • Differentiate oral P2Y12 inhibitors with respect to their clinical pharmacology and examine the select differences between oral antiplatelet therapies
  • Describe the role of BRILINTA in reducing the risk of cardiovascular events in patients with acute coronary syndrome, history of myocardial infarction, and high-risk coronary artery disease without prior myocardial infarction

Ted Okerson, MD, FACP, FACE

Sponsored by AstraZeneca Pharmaceuticals, LP